Resident's Forum
RF-VEXAS Syndrome: A New Autoinflammatory Disease
FR-Síndrome VEXAS: Una nueva enfermedad autoinflamatoria
Leído
2663
Vecesse ha leído el artículo
892
Total PDF
1771
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S0001731023003435" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.03.038" "estado" => "S300" "fechaPublicacion" => "2023-06-01" "aid" => "3493" "copyright" => "AEDV" "copyrightAnyo" => "2022" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2023;114:T531-T532" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S0001731023001758" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.06.025" "estado" => "S300" "fechaPublicacion" => "2023-06-01" "aid" => "3421" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2023;114:533-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>" "titulo" => "FR- Formulación tópica de estatinas y colesterol como tratamiento de poroqueratosis" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "533" "paginaFinal" => "535" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF- Topical Cholesterol and Statin Formulation to Treat Porokeratosis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Gimeno Castillo, F.J. de la Torre Gomar" "autores" => array:2 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Gimeno Castillo" ] 1 => array:2 [ "nombre" => "F.J." "apellidos" => "de la Torre Gomar" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023001758?idApp=UINPBA000044" "url" => "/00017310/0000011400000006/v1_202306061231/S0001731023001758/v1_202306061231/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0001731022010626" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.03.033" "estado" => "S300" "fechaPublicacion" => "2023-06-01" "aid" => "3346" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2023;114:531-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>" "titulo" => "FR - Síndrome VEXAS: Una nueva enfermedad autoinflamatoria" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "531" "paginaFinal" => "532" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF - VEXAS Syndrome: A New Autoinflammatory Disease" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Fernández-Parrado, H. Perandones-González" "autores" => array:2 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Fernández-Parrado" ] 1 => array:2 [ "nombre" => "H." "apellidos" => "Perandones-González" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022010626?idApp=UINPBA000044" "url" => "/00017310/0000011400000006/v1_202306061231/S0001731022010626/v1_202306061231/es/main.assets" ] "asociados" => array:1 [ 0 => array:18 [ "pii" => "S0001731022010626" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.03.033" "estado" => "S300" "fechaPublicacion" => "2023-06-01" "aid" => "3346" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2023;114:531-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>" "titulo" => "FR - Síndrome VEXAS: Una nueva enfermedad autoinflamatoria" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "531" "paginaFinal" => "532" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF - VEXAS Syndrome: A New Autoinflammatory Disease" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Fernández-Parrado, H. Perandones-González" "autores" => array:2 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Fernández-Parrado" ] 1 => array:2 [ "nombre" => "H." "apellidos" => "Perandones-González" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022010626?idApp=UINPBA000044" "url" => "/00017310/0000011400000006/v1_202306061231/S0001731022010626/v1_202306061231/es/main.assets" ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Resident's Forum</span>" "titulo" => " RF-VEXAS Syndrome: A New Autoinflammatory Disease" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T531" "paginaFinal" => "T532" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Fernández-Parrado, H. Perandones-González" "autores" => array:2 [ 0 => array:4 [ "nombre" => "M." "apellidos" => "Fernández-Parrado" "email" => array:1 [ 0 => "miriam.fernandez.parrado@navarra.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "H." "apellidos" => "Perandones-González" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario de Navarra, Navarra, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Dermatología, Complejo Asistencial Universitario de León, León, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR-Síndrome VEXAS: Una nueva enfermedad autoinflamatoria" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">VEXAS syndrome—a new autoinflammatory disease involving Vacuoles, the E-1 ubiquitin activating enzyme, X-linkage, Autoinflammation, and Somatic mutations—was first described in 2020.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> This syndrome is caused by an acquired somatic mutation with an amino acid change (a missense mutation) in the <span class="elsevierStyleItalic">UBA1</span> gene.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> The <span class="elsevierStyleItalic">UBA1</span> gene codes for the E-1 ubiquitin-activating enzyme needed to initiate ubiquitination, a posttranslational modification that regulates intracellular signaling and protein degradation and plays a key role in autophagy.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> This rare entity is caused by acquired mosaic mutations of the <span class="elsevierStyleItalic">UBA1</span> gene in myeloid progenitor cells.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Identifying new diseases with heterogeneous phenotypes and diverse clinical manifestations, such as autoinflammatory diseases, is a challenge. The aforementioned study, rather than grouping together patients with similar phenotypes and identifying mutations responsible for clinical pictures, took the inverse diagnostic approach and focused on genotypes.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> The genome of patients suffering from undiagnosed systemic inflammatory processes and/or recurrent fever was sequenced, and in 25 men a common mutation was detected in codon 41 of the <span class="elsevierStyleItalic">UBA1</span> gene on the X chromosome. To date, 3 variants of the mutation have been identified—pMet41Thr, pMet41Val, and pMet41Leu—and although they had initially only been described in men, they have also been detected in women as a consequence of the inactivation of one X chromosome.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Most of the patients in the first series described presented with recurrent fever, cutaneous manifestations, lung involvement, ear or nose polychondritis, and hematological disorders such as macrocytic anemia or myelodysplastic syndromes.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> Another characteristic of those patients was the presence of vacuoles in erythroid and myeloid precursors in bone marrow biopsies. It is likely that in the future new clinical characteristics, such as eye or gastrointestinal involvement, joint pain, or adenopathy will be added to the initial description of phenotypes.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> The patients in whom the mutation was detected had been diagnosed with, or had met the criteria for, relapsing polychondritis, Sweet syndrome, polyarteritis nodosa (PAN), or giant cell arteritis.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Dermatologic manifestations, which were present in more than 80% of patients, are among the most frequent clinical features and precede systemic symptoms in more than half of the cases.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">1,4</span></a> Cutaneous manifestations can be similar to those of other known dermatoses, such as Sweet syndrome, and may include pink or violaceous edematous papules on the neck and trunk, erythematous-violaceous plaques and nodules, livedo racemose, or vasculitic lesions similar to those found in PAN.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">4</span></a> Histopathologically, the skin lesions are characterized by the presence of a dense dermal neutrophilic infiltrate, with variable leukocytoclastic degradation and vessel infiltration, and in some cases, venous thrombosis. The infiltrate consists of neutrophils mixed with precursor myeloid cells positive for CD163 (immature neutrophils and metamyelocytes).<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">4</span></a> In some cases signs of PAN were found in addition to neutrophilic dermatosis.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">3,4</span></a> Sanger sequencing for <span class="elsevierStyleItalic">UBA1</span> in biopsies suggests that the infiltrate is clonal and that the cutaneous manifestations are therefore probably more a consequence of the infiltrate than of an autoinflammatory state.</p><p id="par0035" class="elsevierStylePara elsevierViewall">An algorithm was recently proposed to detect the mutation in patients previously diagnosed with relapsing polychondritis. Given that frequent and diverse cutaneous manifestations are involved in VEXAS syndrome, it would be useful to reach a similar consensus for male patients diagnosed with Sweet syndrome in dermatology departments.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a></p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Funding</span><p id="par0040" class="elsevierStylePara elsevierViewall">This work has not received any type of funding.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Conflicts of Interest</span><p id="par0045" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:5 [ 0 => array:2 [ "identificador" => "xpalclavsec1648645" "titulo" => "Palabras clave" ] 1 => array:2 [ "identificador" => "xpalclavsec1648646" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 3 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflicts of Interest" ] 4 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1648646" "palabras" => array:5 [ 0 => "VEXAS syndrome" 1 => "<span class="elsevierStyleItalic">UBA1</span> gene" 2 => "Autoinflammatory disease" 3 => "Skin lesions" 4 => "Diagnosis" ] ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0025" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.B. Beck" 1 => "M.A. Ferrada" 2 => "K.A. Sikora" 3 => "A.K. Ombrello" 4 => "J.C. Collins" 5 => "W. Pei" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2026834" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2020" "volumen" => "383" "paginaInicial" => "2628" "paginaFinal" => "2638" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33108101" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0030" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Georgin-Lavialle" 1 => "B. Terrier" 2 => "A.F. Guedon" 3 => "M. Heiblig" 4 => "T. Comont" 5 => "E. Lazaro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjd.20805" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2022" "volumen" => "186" "paginaInicial" => "564" "paginaFinal" => "574" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34632574" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0035" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Zakine" 1 => "B. Schell" 2 => "M. Battistella" 3 => "M.-D. Vignon-Pennamen" 4 => "F. Chasset" 5 => "T. Mahévas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamadermatol.2021.3344" "Revista" => array:6 [ "tituloSerie" => "JAMA Dermatol" "fecha" => "2021" "volumen" => "157" "paginaInicial" => "1349" "paginaFinal" => "1354" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34495287" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0040" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.A. Ferrada" 1 => "K.A. Sikora" 2 => "Y. Luo" 3 => "K.V. Wells" 4 => "B. Patel" 5 => "E.M. Groarke" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.41743" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheumatol" "fecha" => "2021" "volumen" => "73" "paginaInicial" => "1886" "paginaFinal" => "1895" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33779074" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000011400000006/v1_202306061231/S0001731023003435/v1_202306061231/en/main.assets" "Apartado" => array:4 [ "identificador" => "34907" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Foro de Residentes" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011400000006/v1_202306061231/S0001731023003435/v1_202306061231/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023003435?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 13 | 10 | 23 |
| 2024 Octubre | 146 | 54 | 200 |
| 2024 Septiembre | 168 | 36 | 204 |
| 2024 Agosto | 148 | 87 | 235 |
| 2024 Julio | 94 | 41 | 135 |
| 2024 Junio | 99 | 66 | 165 |
| 2024 Mayo | 91 | 49 | 140 |
| 2024 Abril | 79 | 52 | 131 |
| 2024 Marzo | 82 | 49 | 131 |
| 2024 Febrero | 61 | 40 | 101 |
| 2024 Enero | 70 | 23 | 93 |
| 2023 Diciembre | 77 | 23 | 100 |
| 2023 Noviembre | 85 | 48 | 133 |
| 2023 Octubre | 75 | 38 | 113 |
| 2023 Septiembre | 96 | 27 | 123 |
| 2023 Agosto | 79 | 28 | 107 |
| 2023 Julio | 99 | 53 | 152 |
| 2023 Junio | 136 | 50 | 186 |
| 2023 Mayo | 73 | 118 | 191 |
Mostrar todo
